GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Allied Biotech Corp (ROCO:1780) » Definitions » Receivables Turnover

Allied Biotech (ROCO:1780) Receivables Turnover : 3.13 (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Allied Biotech Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Allied Biotech's Revenue for the six months ended in Dec. 2023 was NT$341.1 Mil. Allied Biotech's average Accounts Receivable for the six months ended in Dec. 2023 was NT$108.9 Mil. Hence, Allied Biotech's Receivables Turnover for the six months ended in Dec. 2023 was 3.13.


Allied Biotech Receivables Turnover Historical Data

The historical data trend for Allied Biotech's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allied Biotech Receivables Turnover Chart

Allied Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.57 6.46 6.16 6.51 6.38

Allied Biotech Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.87 2.80 2.64 3.35 3.13

Competitive Comparison of Allied Biotech's Receivables Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Allied Biotech's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Allied Biotech's Receivables Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Allied Biotech's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Allied Biotech's Receivables Turnover falls into.



Allied Biotech Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Allied Biotech's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as

Receivables Turnover (A: Dec. 2023 )
=Revenue / Average Total Inventories
=Revenue (A: Dec. 2023 ) / ((Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count )
=720.431 / ((117.247 + 108.623) / 2 )
=720.431 / 112.935
=6.38

Allied Biotech's Receivables Turnover for the quarter that ended in Dec. 2023 is calculated as

Receivables Turnover (Q: Dec. 2023 )
=Revenue / Average Total Inventories
=Revenue (Q: Dec. 2023 ) / ((Accounts Receivable (Q: Jun. 2023 ) + Accounts Receivable (Q: Dec. 2023 )) / count )
=341.079 / ((109.208 + 108.623) / 2 )
=341.079 / 108.9155
=3.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Allied Biotech  (ROCO:1780) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


Allied Biotech Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Allied Biotech's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Allied Biotech (ROCO:1780) Business Description

Traded in Other Exchanges
N/A
Address
No. 76 Tun Hua S. Road, Sec. 2, 12th Floor, Taipei, TWN
Allied Biotech Corp is a Taiwan based manufacturer of carotenoids. It manufactures carotenoid formulations for the food, supplement and feed industries. The company markets its products under the name Altratene.

Allied Biotech (ROCO:1780) Headlines

No Headlines